TC Biopharm (TCBP) Institutional Ownership $0.87 +0.01 (+1.16%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for TC Biopharm (NASDAQ:TCBP)CurrentInstitutional OwnershipPercentage16.25%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.56M Get TCBP Insider Trade Alerts Want to know when executives and insiders are buying or selling TC Biopharm stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TCBP Institutional Buying and Selling by Quarter Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. TC Biopharm Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC74,000$235K0.0%-75.1%10.882% 11/15/2023Armistice Capital LLC297,500$128K0.0%-43.7%31.316% 11/7/2022Virtu Financial LLC130,005$35K0.0%+454.0%0.342% 8/15/2022KCL Capital L.P.100,000$37K0.0%N/A0.263% 8/11/2022Warberg Asset Management LLC99,165$36K0.0%N/A0.261% (Data available from 1/1/2016 forward) TCBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TCBP shares? During the previous two years, the following institutional investors and hedge funds held shares of TC Biopharm shares: Armistice Capital LLC ($235K), KCL Capital L.P. ($37K), and Warberg Asset Management LLC ($36K), Virtu Financial LLC ($35K).Learn more on TCBP's institutional investors. What percentage of TC Biopharm stock is owned by institutional investors? 16.25% of TC Biopharm stock is owned by institutional investors. Learn more on TCBP's institutional investor holdings. Which institutional investors have been buying TC Biopharm stock? The following institutional investors have purchased TC Biopharm stock in the last 24 months: Virtu Financial LLC ($106.54K), KCL Capital L.P. ($100K), and Warberg Asset Management LLC ($99.17K). How much institutional buying is happening at TC Biopharm? Institutional investors have bought a total of 305,704 shares in the last 24 months. This purchase volume represents approximately $1.03B in transactions. Which TC Biopharm major shareholders have been selling company stock? The following institutional investors have sold TC Biopharm stock in the last 24 months: Armistice Capital LLC ($454.31K). How much institutional selling is happening at TC Biopharm? Institutional investors have sold a total of 454,313 shares in the last 24 months. This volume of shares sold represents approximately $20.56M in transactions. Related Companies: Surrozen Major Shareholders NRx Pharmaceuticals Major Shareholders VBI Vaccines Major Shareholders Cara Therapeutics Major Shareholders Unicycive Therapeutics Major Shareholders PharmaCyte Biotech Major Shareholders Kiora Pharmaceuticals Major Shareholders Cardio Diagnostics Major Shareholders Chromocell Therapeutics Major Shareholders GeoVax Labs Major Shareholders This page (NASDAQ:TCBP) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.